Prospective, Single-centre, Open-Label, Randomised, Pilot Study Assessing the changes in expression of JAK-STAT and Speed & Depth of Remission Induced by Tocilizumab & Methotrexate Combination and Tocilizumab Monotherapy in Patients with Early Rheumatoid Arthritis (TREMERA).
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms TREMERA
- 07 Jun 2017 Biomarkers information updated
- 18 Mar 2015 Planned End Date changed from 30 Oct 2014 to 30 Jan 2015 as per UKCRN record.
- 18 Feb 2015 Accrual to date is 100% according to United Kingdom Clinical Research Network record.